GASTRIC CANCER ADENOCARCINOMA METASTATIC
Clinical trials for GASTRIC CANCER ADENOCARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new GASTRIC CANCER ADENOCARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for GASTRIC CANCER ADENOCARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Three-Drug attack on stomach cancer shows promise
Disease control Recruiting nowThis study is testing whether adding a new targeted drug called Zolbetuximab to standard chemotherapy improves survival for people with advanced stomach or esophageal cancer. It's for patients whose cancer has a specific protein marker called CLDN18.2 and whose disease has progre…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Four-drug attack on stubborn stomach cancer shows promise
Disease control Recruiting nowThis study tests whether combining four different drugs can help control advanced stomach cancer that has continued to grow despite initial immunotherapy treatment. The trial will enroll 68 adults whose cancer has spread and who previously received immunotherapy that stopped work…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Dai, Guanghai • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for tough stomach cancers: first human trial begins
Disease control Recruiting nowThis early-stage study is testing a new drug called BDC-4182 for people with advanced stomach or esophageal cancer that has spread or can't be removed by surgery. The main goals are to find the safest dose and see how well the body handles the drug. Researchers will also check if…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New Three-Drug attack on tough stomach cancer cases
Disease control Recruiting nowThis trial is testing whether adding a drug called lenvatinib to standard immunotherapy and chemotherapy can help people with advanced stomach cancer that has spread to the lining of the abdomen and caused significant fluid buildup. The study aims to find a safe dose and see if t…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC